Product Name :
Repaglinide
Description:
Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. The mechanism of action of repaglinide involves promoting insulin release from β-islet cells of the pancreas.
CAS:
135062-02-1
Molecular Weight:
452.59
Formula:
C27H36N2O4
Chemical Name:
2-ethoxy-4-({[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]carbamoyl}methyl)benzoic acid
Smiles :
CC(C)C[C@H](NC(=O)CC1=CC(OCC)=C(C=C1)C(O)=O)C1=CC=CC=C1N1CCCCC1
InChiKey:
FAEKWTJYAYMJKF-QHCPKHFHSA-N
InChi :
InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Levofloxacin} MedChemExpress|{Levofloxacin} Orthopoxvirus|{Levofloxacin} Purity & Documentation|{Levofloxacin} In Vitro|{Levofloxacin} supplier|{Levofloxacin} Autophagy}
Shelf Life:
≥360 days if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983.{{Levofloxacin} site|{Levofloxacin} Topoisomerase|{Levofloxacin} Biological Activity|{Levofloxacin} References|{Levofloxacin} supplier|{Levofloxacin} Epigenetic Reader Domain} Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus.PMID:23614016 The mechanism of action of repaglinide involves promoting insulin release from β-islet cells of the pancreas.|Product information|CAS Number: 135062-02-1|Molecular Weight: 452.59|Formula: C27H36N2O4|Chemical Name: 2-ethoxy-4-({[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]carbamoyl}methyl)benzoic acid|Smiles: CC(C)C[C@H](NC(=O)CC1=CC(OCC)=C(C=C1)C(O)=O)C1=CC=CC=C1N1CCCCC1|InChiKey: FAEKWTJYAYMJKF-QHCPKHFHSA-N|InChi: InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥360 days if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|
